President Trump is canceling nearly $1 billion in spending approved by Congress, and most of the cuts are focused on HHS programs that serve refugees and unaccompanied minors.

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of ...

With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of ...

The Justice Department said in June that it would no longer enforce laws that prioritized people with disabilities living and ...

Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand ...

The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an ...

Gilead Sciences’ top executives have been emphatically bullish about the biotech’s years-long push to develop drugs for ...

Klomp is currently senior adviser to health secretary Robert F. Kennedy Jr. He was advanced by the Senate Committee on ...

During a Senate hearing today, Heidi Overton, the nominee to lead the FDA, plans to emphasize the need for speed and ...

Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration, was grilled by senators on hot-button ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Exclusive: Heidi Overton plans to tell senators she will speed up biomedical research, working with FDA staff.